Relypsa, Inc., a pharmaceutical manufacturing and research company, is set to expand into 200 Cardinal Way within the Britannia Seaport Centre in Redwood City this winter after signing a 10-year lease that commences in December.
Relypsa, Inc., a pharmaceutical manufacturing and research company, is set to expand into 200 Cardinal Way within the Britannia Seaport Centre in Redwood City this winter after signing a 10-year lease that commences in December.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In